Currently, the World Health Organization (WHO) and multiple agencies led by the CDC in the United States are studying the use of expanded MSCs as a possible treatment for COVID-1913.The limited but emerging evidence regarding MSCs in managing COVID-19 suggests an urgent mandate for more clinical trials to determine the direct impact these regenerative cells have on patient recovery, which may point in favour of uncovering the potential applications of MSCs to treat COVID-19.